WHO Biomanufacturing Workforce Training Initiative

WHO Biomanufacturing Workforce Training Initiative

 

Low- and middle- income countries (LMICs) that rely heavily on importation to meet public health needs are at great risk for disparity in timely, equitable access to essential medical products. COVID-19 showed that global supply chains are vulnerable to disruptions and global manufacturing capacity of priority medical products is concentrated in only a few countries/regions, which contributed to the disparity in access experienced by LMICs during the pandemic. 

The pandemic also led to unprecedented effort in vaccine development and production and strongly reminded of the growing opportunity biological products represent in combatting leading causes of death and disability worldwide such as infectious diseases, cancer, and diabetes. Biological products, such as vaccines, monoclonal antibodies and insulin, are manufactured through complex bioproduction processes, requiring specialized expertise and additional measures to consistently produce them with assured quality, safety and efficacy. However, biomanufacturing capacity in LMICs is low, partly due to the lack of appropriately qualified and experienced workforce to ensure the development and production of quality, safe and effective biological products. Existing biomanufacturing training facilities are primarily in high-income countries and operate on a high fee-based system, making continuing trainings not readily accessible to enough trainees from LMICs.

Therefore, there is a need for a concerted effort to provide accessible and systematic training to support LMICs’ biomanufacturing capacities, with a curriculum based on WHO and international norms and standards, adapted to their needs and on the competencies and skills required in the bioproduction sector that is evolving at a rapid pace. To address this need, WHO established the WHO Biomanufacturing Workforce Training Initiative.

The WHO Biomanufacturing Workforce Training Initiative supports countries, particularly LMICs, to develop the workforce with relevant skills for biomanufacturing with a comprehensive range of trainings and training modalities (e.g. virtual, classroom, hands-on training) to suit their identified needs. Coordinated and managed by Dr Jicui Dong, Unit Head of the Local Production and Assistance Unit, on behalf of the Access to Medicines and Health Products Division at WHO with close collaboration from the WHO Academy and WHO Science Division, this initiative will have three pillars: existing capacity building activities within WHO, the Global Training Hub for Biomanufacturing and regional training centers.

 

WHO capacity building programmes

Global Training Hub for Biomanufacturing

Regional training centers

Organized by the Local Production and Assistance Unit, WHO provides innovative, progressively in-depth and needs-based capacity building and technical assistance to manufacturers and Member States to achieve sustainable and quality local production and technology transfer. Different modalities, such as virtual, in-person and hands-on training using real-life scenarios, are used in programmes such as:

  • Annual Virtual cGMP Training Marathons for Vaccine Manufacturing
  • The Week of Quality and other CMC trainings on vaccines and other medical products
  • Regional holistic training workshops on key enablers for sustainable local production

 

The Global Training Hub for Biomanufacturing (GTH-B) was established in 2023 under a Memorandum of Understanding between the Republic of Korea and WHO. Located in the Republic of Korea, the GTH-B provides programs to LMICs to build workforce capacity in the development and manufacture of biological products such as vaccines and cancer medicines. Training at the GTH-B includes hands-on training in manufacturing facilities and courses in manufacturing best practices and vaccinology. 

Aligned with the recommendations of the 2nd World Local Production Forum, regional training centers will be part of a network to address geographical diversity and synchronize resources. These centers will provide accessible training with curricula that are suited to the needs of the region, aligned with the GTH-B and existing WHO capacity-building activities and do not compete with each other. A call for expressions of interest is currently published and open for training centers interested in joining the network under the WHO Biomanufacturing Workforce Training Initiative.  

 

 

Call for Applications

Call for Expression of Interest

For more information about the Local Production and Assistance Unit, and other initiatives: 

LPA Website

LPA X (ex-Twitter)

LPA generic email